In conclusion, the current study provided novel evidence that miR-135b is significantly down-regulated in osteosarcoma clinical specimens and appears to function as a tumor suppressor in osteosarcoma through the regulation of c-Myc expression, cell migration, and cell invasion. The gene discussed is MYC; the disease is neoplasm.